Index to be published 28 November 2012

6 November 2012 |

The analysis is nearing completion and we are happy to announce that the 2012 Access to Medicine Index will be published on Wednesday, 28 November. “We are publishing the Index for the third time, and it has matured to the point that we are now able to provide some robust trend analysis on how individual companies, and the industry as a whole, are evolving their approach to access to medicine,” says Wim Leereveld, CEO of the Access to Medicine Foundation. “With funding secured for the next 5 years, we will be able to continue to produce an independent, transparent league table that provides insight and, we hope, encourages pharmaceutical companies to step up their efforts to make medical products and technologies more affordable and accessible to the 2 billion people in developing countries who need them.”

Latest league table of pharma performance

The Access to Medicine Index ranks the top 20 pharmaceutical companies on their efforts to make drugs and other medical products more available and affordable to people in developing countries. This year’s Index will present updated rankings and sub-rankings per key area of activity, showing today’s leaders, risers and fallers. In addition, it will report on relevant industry trends and key findings, as well as provide a detailed analysis of who’s doing what in key areas such as pricing policies, R&D and patents.

What’s new in 2012?

To enable comparability with the 2010 Index, the development of the methodology for the 2012 Index has been evolutionary rather than revolutionary, and the analytical framework remains the same as it was in 2010. This means we can now provide valuable insight into the progress made by the various pharmaceutical companies over the past two years in terms of their access to medicine initiatives. 

In addition, in alignment with Millennium Development Goals 5.A, 5.B, 4, the disease scope of the Index has been expanded to include maternal health and neonatal infections, which means that the Index shows what companies are doing specifically in these areas. The geographical scope has also been expanded to 103 countries, which means that the companies’ activities are now being measured in 18 additional countries, including South Africa, Surinam, Iraq, Algeria and Afghanistan.

Publication and availability

As of 28 November 2012, the complete Access to Medicine Index report can be downloaded free of charge from our For media enquiries and requests for interviews, please contact Suzanne Wolf  + 31 (0) 23 53 39 187.

You are here